Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia.
2006
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
2009 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation
2011 StandoutNobel
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Mechanisms of Thrombus Formation
2008 Standout
Primary Pulmonary Hypertension
2000
The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics
2008 Standout
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
Pheochromocytoma as an Endocrine Emergency
2003
Phaeochromocytoma
2005 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Exercise Standards for Testing and Training
2013 Standout
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Clinical classification of pulmonary hypertension
2004 Standout
Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation.
1994
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry
2013
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function
2008
Inhaled nitric oxide therapy in premature newborns
2006
Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension
2005
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy
2012
Antithrombotic Therapy for VTE Disease
2012 Standout
Executive Summary
2012 Standout
Role of NOS2 in pulmonary injury and repair in response to bleomycin
2015
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
2015 Standout
Myocarditis
2011 Standout
Pediatricians and the Promotion and Support of Breastfeeding
2008
Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
2004
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
2006 StandoutNobel
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
The Pediatric Radiofrequency Ablation Registry's Experience with Ebstein's Anomaly
1998
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Hypertrophic Cardiomyopathy
2002 Standout
Antithrombotic Therapy in Neonates and Children
2008
Antithrombotic Therapy in Neonates and Children
2012
Pulmonary Arterial Hypertension
2004
Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure
2006
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Frequency of Cardiac Death in Children With Idiopathic Dilated Cardiomyopathy
2009
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The human side of hypoxia‐inducible factor
2008 StandoutNobel
Myocarditis
2009 Standout
Bronchopulmonary Dysplasia
2001 Standout
Pulmonary Arterial Hypertension in France
2006 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Breastfeeding and the Use of Human Milk
2012 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children
2007
Magnesium in Man: Implications for Health and Disease
2014 Standout
Radiofrequency Catheter Ablation in Infants ≤18 Months Old
2001
Hypertrophic cardiomyopathy: an important cause of sudden death.
1984
Early Inhaled Nitric Oxide Therapy in Premature Newborns With Respiratory Failure
2007
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Pulmonary Arterial Hypertension
2006
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Recent Advances in Endothelin Research on Cardiovascular and Endocrine Systems.
1994
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension
2002
PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern
2012
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism
2016
Enlargement of Catheter Ablation Lesions in Infant Hearts With Cryothermal Versus Radiofrequency Energy
2011
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Anesthesia for Patients with Pheochromocytoma
1987
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study).
2007
Surgical intervention and support for cardiomyopathies of childhood
1992
Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial
1999
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
2018 StandoutNobel
Works of Michael S. Schaffer being referenced
Prospective Assessment after Pediatric Cardiac Ablation:
2004
Device Closure of Secundum Atrial Septal Defects in Children <15 kg
2012
Mortality following radiofrequency catheter ablation (from the Pediatric Radiofrequency Ablation Registry)
2000
Circulating Immunoreactive Endothelin-1 in Children with Pulmonary Hypertension: Association with Acute Hypoxic Pulmonary Vasoreactivity
1993
The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation
2003
Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia
2004
Inadvertent Atrioventricular Block During Radiofrequency Catheter Ablation
1996
The St. Jude medical cardiac valve in infants and children: Role of anticoagulant therapy
1987
Catecholamine cardiomyopathy: An unusual presentation of pheochromocytoma in children
1981
Inhaled Nitric Oxide in the Management of a Premature Newborn With Severe Respiratory Distress and Pulmonary Hypertension
1993
Hypertrophic cardiomyopathy presenting before 2 years of age in 13 patients
1983